Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Blix

Showing results (131-140 of 147) with videos related to

Pageof 15
Sort By:
European Journal of Oral Sciences|July 9, 2022
Expression and function of resolvin RvD1<sub>n-3 DPA</sub> receptors in oral epithelial cellsMaria G Balta, Olav Schreurs, Trond V Hansen, et al.
International Journal of Cancer|September 2, 2025
Anti-Her2 therapy patterns in metastatic breast cancer-Real-world data suggest undertreatmentKathrine F Vandraas, Sarah Hjorth, Cassia B Trewin-Nybråten, et al.
Breast Cancer Research and Treatment|July 22, 2025
Higher pre-diagnostic serum syndecan-4 levels are associated with increased breast cancer risk: a case-cohort studyEndre Gabrielsen, Tom Wilsgaard, Hanne Frydenberg, et al.
BMC Public Health|January 17, 2019
Knowledge of antibiotics and antibiotic resistance among Norwegian pharmacy customers - a cross-sectional studyMarit Waaseth, Abdifatah Adan, Ingrid L Røen, et al.
Clinical and Translational Radiation Oncology|April 17, 2018
Dosimetric assessment of an Atlas based automated segmentation for loco-regional radiation therapy of early breast cancer in the Skagen Trial 1: A multi-institutional studyAhmed R Eldesoky, Giulio Francolini, Mette S Thomsen, et al.
Journal of Wildlife Diseases|June 29, 2012
Serum chemistry and antibodies against pathogens in antarctic fur seals, Weddell seals, crabeater seals, and Ross sealsMorten Tryland, Ingebjørg H Nymo, Ole Nielsen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 30, 2017
Quality assessment of delineation and dose planning of early breast cancer patients included in the randomized Skagen Trial 1Giulio Francolini, Mette S Thomsen, Esben S Yates, et al.
Genome Medicine|December 5, 2023
Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer developmentOleksii Nikolaienko, Hans P Eikesdal, Elisabet Ognedal, et al.
Breast (Edinburgh, Scotland)|January 7, 2026
Neoadjuvant endocrine therapy with sequential palbociclib and chemotherapy based on Ki67 status in stage II-III breast cancer: An open-label, phase II studyChristina Engebrethsen, Synnøve Yndestad, Mari E Rasmussen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 5, 2016
Internal and external validation of an ESTRO delineation guideline - dependent automated segmentation tool for loco-regional radiation therapy of early breast cancerAhmed R Eldesoky, Esben S Yates, Tine B Nyeng, et al.
Pageof 15

Showing results (131-140 of 147) with videos related to

Sort By:
Pageof 15
European Journal of Oral Sciences|July 9, 2022
Expression and function of resolvin RvD1<sub>n-3 DPA</sub> receptors in oral epithelial cellsMaria G Balta, Olav Schreurs, Trond V Hansen, et al.
International Journal of Cancer|September 2, 2025
Anti-Her2 therapy patterns in metastatic breast cancer-Real-world data suggest undertreatmentKathrine F Vandraas, Sarah Hjorth, Cassia B Trewin-Nybråten, et al.
Breast Cancer Research and Treatment|July 22, 2025
Higher pre-diagnostic serum syndecan-4 levels are associated with increased breast cancer risk: a case-cohort studyEndre Gabrielsen, Tom Wilsgaard, Hanne Frydenberg, et al.
BMC Public Health|January 17, 2019
Knowledge of antibiotics and antibiotic resistance among Norwegian pharmacy customers - a cross-sectional studyMarit Waaseth, Abdifatah Adan, Ingrid L Røen, et al.
Clinical and Translational Radiation Oncology|April 17, 2018
Dosimetric assessment of an Atlas based automated segmentation for loco-regional radiation therapy of early breast cancer in the Skagen Trial 1: A multi-institutional studyAhmed R Eldesoky, Giulio Francolini, Mette S Thomsen, et al.
Journal of Wildlife Diseases|June 29, 2012
Serum chemistry and antibodies against pathogens in antarctic fur seals, Weddell seals, crabeater seals, and Ross sealsMorten Tryland, Ingebjørg H Nymo, Ole Nielsen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 30, 2017
Quality assessment of delineation and dose planning of early breast cancer patients included in the randomized Skagen Trial 1Giulio Francolini, Mette S Thomsen, Esben S Yates, et al.
Genome Medicine|December 5, 2023
Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer developmentOleksii Nikolaienko, Hans P Eikesdal, Elisabet Ognedal, et al.
Breast (Edinburgh, Scotland)|January 7, 2026
Neoadjuvant endocrine therapy with sequential palbociclib and chemotherapy based on Ki67 status in stage II-III breast cancer: An open-label, phase II studyChristina Engebrethsen, Synnøve Yndestad, Mari E Rasmussen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 5, 2016
Internal and external validation of an ESTRO delineation guideline - dependent automated segmentation tool for loco-regional radiation therapy of early breast cancerAhmed R Eldesoky, Esben S Yates, Tine B Nyeng, et al.
Pageof 15